Record of GMO and GM Product Dealings under Section 138 of the Gene Technology Act 2000 Dealings Involving GM products - therapeutics NB - All of these products have been approved for supply in Australia by the Therapeut - Amgen - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2012-08-18 10:04:06 Peptide hormones Amgen Growth factors Interferon Escherichia coli Granulocyte colony-stimulating factor Genentech Insulin Saizen Biology Cytokines Eli Lilly and Company		Record of GMO and GM Product Dealings under Section 138 of the Gene Technology Act 2000 Dealings Involving GM products - therapeutics NB - All of these products have been approved for supply in Australia by the Therapeut Add to Reading List Source URL: www.ogtr.gov.au Download Document from Source Website File Size: 23,60 KB Share Document on Facebook

	PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno DocID: 1vlwz - View Document
	IMPORTANT PLEASE READ PART III: CONSUMER INFORMATION INTRON A® interferon alfa-2b This leaflet is part III of a three-part "Product Monograph" DocID: 1uNBi - View Document
	Evaluation of Interferon-gamma-Producing T Cells DocID: 1uFKZ - View Document
	PRODUCT MONOGRAPH INTRON A® interferon alfa-2b Lyophilized Powder with Diluent: 10 million IU interferon alfa-2b/vial DocID: 1umTG - View Document
	  Data Sheet Recombinant Human Interferon-gamma (rh IFN-) Preclinical Grade - Order No.: µg) DocID: 1u1rK - View Document